First pharmacophoric hypothesis for T-type calcium channel blockers

<scp>CHARMM</scp>: A program for macromolecular energy, minimization, and dynamics calculations

Bernard R. Brooks, Robert E. Bruccoleri, Barry D. Olafson et al. · Journal of Computational Chemistry · 1983 · 14.9K citations

Engineering, Molecular Biology, Empirical Energy Function +21

Poling: Promoting conformational variation

Andrew Smellie, Steven L. Teig, Peter Towbin · Journal of Computational Chemistry · 1995 · 441 citations

Geometric Modeling, Majority Influence, Pattern Formation +11

Selective inhibition of T-type Ca2+ channels by Ro 40-5967.

Santosh Kumar Mishra, Kent Hermsmeyer · Circulation Research · 1994 · 369 citations

Ca2+ Channel Types, Pharmacotherapy, Cellular Physiology +19

Life-Threatening Interaction of Mibefradil and β-Blockers With Dihydropyridine Calcium Channel Blockers

Michael E. Mullins · JAMA · 1998 · 154 citations

Withdrawal of Posicor From Market

Ruth SoRelle · Circulation · 1998 · 90 citations · Full text

Market Manipulation, Market Analysis, Business +4